The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.65BCNY
544.75M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue (TTM)
458.62MCNY
68.44M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
-101.17%
Updated Sep 21, 2026
Beta
0.0920x
vs all stocks
Updated Sep 21, 2026
52-Week Change
-58.71%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
3.65BCNY
544.75M · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
4.45BCNY
663.92M · vs all stocks (USD)
Updated Sep 21, 2026
Forward P/E
20.62x
Updated Sep 21, 2026
Price to Sales (TTM)
7.96x
Updated Sep 21, 2026
Price to Book (MRQ)
11.09x
Updated Sep 21, 2026
Enterprise to Revenue
9.70x
Updated Sep 21, 2026
Enterprise to EBITDA
-12.26x
Updated Sep 21, 2026
Gross Margin
10.82%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -11.61%.Updated Sep 21, 2026
Profit Margin
-101.17%
Updated Sep 21, 2026
Operating Margin
-49.79%
Updated Sep 21, 2026
Return on Assets (TTM)
-11.50%
Updated Sep 21, 2026
Return on Equity (TTM)
-80.93%
Updated Sep 21, 2026
Revenue (TTM)
458.62MCNY
68.44M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
0.9570CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
-44.50%
Updated Sep 21, 2026
Gross Profit (TTM)
-53.22MCNY
-7.94M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
-362.89MCNY
-54.15M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
-463.99MCNY
-69.24M · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
-44.52%
Updated Sep 21, 2026
Operating Cash Flow (TTM)
83.89MCNY
12.52M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
239.70MCNY
35.77M · vs all stocks (USD)
Updated Sep 21, 2026
Payout Ratio
0.00%
Updated Sep 21, 2026
Minority Interest (Equity)
5.63MCNYFY2025 · Dec 31, 2025
Revenue
590.84MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
532.84MCNYFY2025 · Dec 31, 2025
Gross Profit
58.01MCNYFY2025 · Dec 31, 2025
Operating Income
-236.78MCNY
-35.33M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-397.11MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-1.90MCNYFY2025 · Dec 31, 2025
Net Income
-395.21MCNYFY2025 · Dec 31, 2025
EBIT
-363.29MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-186.25MCNYFY2025 · Dec 31, 2025
Research & Development
132.27MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
19.10MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
2.71MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
738.37KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
33.82MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.8255CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.8255CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
478.45MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
478.45MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-395.21MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
248.63KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-37.56MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-69.03MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
139.60MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-395.21MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
34.54MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
205.87MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
117.24MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-31.47MCNYFY2025 · Dec 31, 2025
Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025
Purchase of Investments
-24.96MCNYFY2025 · Dec 31, 2025
Sale of Investments
38.31MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-18.12MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
490.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-605.43MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-33.10MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-11.32MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-159.86MCNYFY2025 · Dec 31, 2025
Shares Outstanding
478.45MSharesUpdated Sep 21, 2026
Float Shares
434.42MSharesUpdated Sep 21, 2026
% Held by Insiders
12.73%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
3.40%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
131.06MCNY
19.56M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
0.2740CNYUpdated Sep 21, 2026
Total Debt (MRQ)
924.21MCNY
137.91M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
2.76x
Updated Sep 21, 2026
Current Ratio (MRQ)
1.41x
Updated Sep 21, 2026
Book Value per Share (MRQ)
0.6880CNYUpdated Sep 21, 2026
Total Assets
1.77BCNY
263.58M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
841.19MCNYFY2025 · Dec 31, 2025
Total Liabilities
1.36BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
925.22MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
822.64MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
535.27MCNYFY2025 · Dec 31, 2025
Cash
180.77MCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.57MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
184.34MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
12.50MCNYFY2025 · Dec 31, 2025
Accounts Receivable
234.50MCNYFY2025 · Dec 31, 2025
Inventory
309.89MCNYFY2025 · Dec 31, 2025
Accounts Payable
173.20MCNYFY2025 · Dec 31, 2025
Short-term Debt
123.70MCNYFY2025 · Dec 31, 2025
Long-term Debt
811.95MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
478.45MCNYFY2025 · Dec 31, 2025
Retained Earnings
-770.39MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
408.49MCNY
60.96M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
0.00CNYFY2025 · Dec 31, 2025
52-Week Low
6.08CNYUpdated Sep 21, 2026
52-Week High
20.71CNYUpdated Sep 21, 2026
52-Week Change
-58.71%
vs all stocks
Updated Sep 21, 2026
Beta
0.0920x
vs all stocks
Updated Sep 21, 2026
50-Day MA
8.50CNYUpdated Sep 21, 2026
200-Day MA
12.18CNYUpdated Sep 21, 2026
Avg 10-Day Volume
20.97MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
33.69MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
-0.9700CNYUpdated Sep 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.87: distress zoneCritical
Altman Z-Score: 0.87
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Levered free cash flow is $35.77M, above the global median of $18.73MNotable